Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity
Authors:
- Bradley W. BlaserBBBradley W. Blaser
- Noah R. SchwindNSNoah R. Schwind
- Seth KarolSKSeth Karol
- Dennis ChangDCDennis Chang
- Samuel ShinSSSamuel Shin
- Sameek RoychowdhurySRSameek Roychowdhury
- Brian BecknellBBBrian Becknell
- Amy K. FerketichAFAmy K. Ferketich
- Donna F. KusewittDKDonna F. Kusewitt
- Bruce R. BlazarBBBruce R. Blazar
- Michael A. CaligiuriMCMichael A. Caligiuri
Open Access
- 1 October 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (7) , 2463-2469
Abstract
The “holy grail” of allogeneic stem cell transplantation is to preserve the graft-versus-tumor (GVT) effect while eliminating graft-versus-host disease (GVHD). Endogenous donor-derived interleukin 15 (IL-15) has been implicated in the pathogenesis of acute GVHD, yet the mechanism by which it impacts this lethal process remains unclear. Using the well-described and clinically relevant C57BL/6 → B6D2F1 murine model of acute GVHD, we demonstrate that in trans presentation of IL-15 by donor bone marrow–derived cells is required for the rapid onset of acute GVHD. Recipients of IL-15–/– C57BL/6 bone marrow cells show diminished type 1 polarization of T cells, yet there is no decrease in donor T-cell reconstitution. A molecular basis for these findings is provided with the observation that expression of T-bet, the master control gene for type 1 T-cell functions, is necessary for IL-15–mediated acute GVHD lethality. Finally, we demonstrate that in the absence of donor-derived IL-15, the GVT effect is maintained. These findings thus establish a mechanism by which endogenous donor-derived IL-15 impacts the pathobiology of acute GVHD and GVT activity.Keywords
This publication has 49 references indexed in Scilit:
- Donor-derived IL-15 is critical for acute allogeneic graft-versus-host diseaseBlood, 2005
- Failed Adoptive Immunotherapy with Tumor-Specific T CellsCancer Research, 2004
- CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effectsBlood, 2003
- IL-15Rα Recycles and Presents IL-15 In trans to Neighboring CellsImmunity, 2002
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantationJournal of Clinical Investigation, 2001
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Fas ligand- mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease.Journal of Clinical Investigation, 1998
- Abnormal Development of Intestinal Intraepithelial Lymphocytes and Peripheral Natural Killer Cells in Mice Lacking the IL-2 Receptor β ChainJournal of Experimental Medicine, 1997
- ENDOGENOUS IFN-GAMMA DURING HUMAN BONE MARROW TRANSPLANTATIONTransplantation, 1990